 |
|
|
|
|
|
Dec.
|
2004
|
Establised
GMP manufactuing facility
|
|
Oct.
|
2003
|
Merge
Jeil Biotechservices Inc.
(JBI)
|
|
May
|
2002
|
U.S patent
and PCT applications for
massive 'direct' functional
genomics-¥± |
|
Mar.
|
2002
|
U.S patent
and PCT applications for
massive 'direct' functional
genomics-¥°
|
|
Mar.
|
2002
|
Movement
to a newly built R&D
Building 716-3, Hosandong,
Dalseogu, Daegu |
|
Jul.
|
2001
|
Funding by
equity investment |
|
May |
2001
|
Patent applications for high
throughput functional genomics using fourth
generation
antisense |
|
Mar.
|
2001
|
Patent applications for cytokine gene therapy of kidney
failure |
|
Oct.
|
2000
|
Certified as a BIO-venture
company (No. 2000132771-0550) by the Korean Authorization
Agency for Science and Technology |
|
June
|
2000
|
Patent application for fifth
generation antisense |
|
Apr.
|
2000
|
WelGENE Research Division
formed |
|
Apr.
|
2000
|
Patent application for third
generation antisense |
|
Mar.
|
2000
|
WelGENE established with
private funding |
|
Apr.
|
1999
|
Patent
application for fourth generation
antisense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
